Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Growth in Short Interest

Key Points

• Inventiva S.A. Sponsored ADR experienced a significant increase in short interest, rising by 53.1% in August to a total of 44,100 shares.
• IVA stock is currently valued at $5.31 after a 5.3% decline, with a consensus target price of $14.83 based on analyst ratings.
• Institutional investors hold 19.06% of Inventiva's stock, with Wealth Enhancement Advisory Services recently acquiring 10,715 shares valued at approximately $32,000.

Inventiva S.A. Sponsored ADR (NASDAQ:IVA - Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 44,100 shares, an increase of 53.1% from the August 15th total of 28,800 shares. Based on an average daily trading volume, of 35,900 shares, the short-interest ratio is presently 1.2 days. Approximately 0.1% of the shares of the stock are short sold. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 35,900 shares, the short-interest ratio is presently 1.2 days.

Analyst Upgrades and Downgrades

A number of research firms have commented on IVA. Piper Sandler began coverage on shares of Inventiva in a research note on Wednesday, August 27th. They issued an "overweight" rating and a $26.00 price target for the company. Guggenheim boosted their price objective on shares of Inventiva from $9.00 to $13.00 and gave the stock a "buy" rating in a report on Tuesday, September 2nd. Finally, HC Wainwright started coverage on shares of Inventiva in a report on Wednesday, September 3rd. They issued a "buy" rating and a $20.00 price objective for the company. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $14.83.

Inventiva Trading Up 4.2%

Shares of IVA traded up $0.23 during mid-day trading on Friday, reaching $5.65. The company's stock had a trading volume of 63,054 shares, compared to its average volume of 73,690. The company's fifty day moving average price is $4.36 and its two-hundred day moving average price is $3.64. Inventiva has a 52 week low of $1.53 and a 52 week high of $6.50.

Institutional Investors Weigh In On Inventiva

An institutional investor recently bought a new position in Inventiva stock. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Inventiva S.A. Sponsored ADR (NASDAQ:IVA - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,715 shares of the company's stock, valued at approximately $32,000. 19.06% of the stock is owned by institutional investors and hedge funds.

Inventiva Company Profile

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.